Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Cerenia   
Auth. number : EU/2/06/062
INN : Maropitant
ATC: Anatomical main group: QA - Alimentary tract and metabolism
Therapeutic subgroup: QA04 - Antiemetics and antinauseants
Pharmacological subgroup: QA04A - Antiemetics and antinauseants
Chemical subgroup: QA04AD - Other antiemetics
Chemical substance: QA04AD90 - Maropitant
(See WHO ATCvet Index)
Indication: For the prevention of nausea induced by chemotherapy.
For the prevention of vomiting induced by motion sickness.
For the prevention and treatment of vomiting, in conjunction with Cerenia Solution For
Injection and in combination with other supportive measures.
Marketing Authorisation Holder: Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/10/2006 Centralised - Authorisation EMEA/V/C/106 (2006)4400 of 29/09/2006
04/09/2007 Centralised - Variation EMEA/V/C/106/IA/1
20/11/2007 Centralised - Variation EMEA/V/C/106/IB/3
Updated with Decision(2008)291 of 17/01/2008
21/01/2008 Centralised - Variation EMEA/V/C/106/II/2 (2008)291 of 17/01/2008
18/02/2008 Corrigendum
25/09/2008 Centralised - Variation EMEA/V/C/106/IB/4
20/11/2008 Centralised - Variation EMEA/V/C/106/II/5 (2008)7311 of 18/11/2008
27/05/2009 Centralised - Variation EMEA/V/C/106/IB/7
07/09/2009 Centralised - Variation EMEA/V/C/106/II/6 (2009)6829 of 02/09/2009
22/12/2009 Centralised - Variation EMEA/V/C/106/IB/8
24/03/2010 Centralised - Variation EMEA/V/C/106/IA/11
24/03/2010 Centralised - Variation EMEA/V/C/106/IB/10
Updated with Decision(2010)7213 of 14/10/2010
24/03/2010 Centralised - Variation EMEA/V/C/106/IA/9
18/10/2010 Centralised - Variation (2010)7213 of 14/10/2010
10/08/2011 Centralised - Renewal EMEA/V/C/106/R/12 (2011)5823 of 05/08/2011
14/11/2011 Centralised - Variation EMEA/V/C/106/IB/15
Updated with Decision(2012)191 of 13/01/2011
17/01/2012 Centralised - Variation EMEA/V/C/106/106/II/14 (2012)191 of 13/01/2011
17/04/2012 Centralised - Variation EMEA/V/C/106/II/13 (2012)2541 of 13/04/2012
30/07/2012 Corrigendum (2012)2541 corr of 26/07/2012
16/05/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/106/T/19 (2013)2895 of 14/05/2013
19/08/2013 Centralised - Variation EMEA/V/C/106/II/18 (2013)5483 of 14/08/2013
11/06/2014 Centralised - Variation EMEA/V/C/106/II/22 (2014)3951 of 06/06/2014